SinoGreenTech Academic Portal
ZY
Verified CAS / Academic Author2 Decoded Studies

Prof. ZHANG Yuhao

Sun Yat-sen University

Research Publications & English Decoded Briefs

Showing 2 publications
SCIENCE CHINA Materials2026DOI: 10.1007/s40843-025-4004-3

Boosting oxygen evolution through asymmetric CoIII–O–MoV motif-modulated spinel active sites

The development of efficient and stable oxygen evolution reaction (OER) electrocatalysts is critical for clean energy technologies, yet conventional cobalt-based spinel catalysts often suffer from insufficient activity and structural instability under operating conditions. To address these challenges, this study proposes and constructs a cation-ordered spinel-like catalyst (HVI Metal-CoMoO4/NF). The unique crystalline framework induces significant Jahn-Teller distortion and pre-stabilizes a Co2+/Co3+ mixed-valence state at the cobalt active centers via asymmetric Co–O–Mo bridges, effectively optimizing bulk charge transport. Electrochemical tests demonstrate that its performance significantly surpasses that of benchmark materials, requiring only an overpotential of 307 mV to drive a current density of 100 mA cm−2 in 1.0 M KOH, with a Tafel slope of 63.13 mV dec−1, maintaining stable operation for over 320 h at high current density. Crucially, our structural and in situ characterization results clearly reveal a stable and well-crystallized reconstruction behavior from the surface into the bulk of the spinel-like pre-catalyst during the OER. This work fundamentally addresses the challenges of disordered reconstruction and unstable active phases in traditional spinel catalysts, providing a paradigm for regulating the dynamic evolution of electrocatalysts through precise structural design.

SCIENCE CHINA Materials2025DOI: 10.1007/s40843-025-3360-x

A conjugate strategy capable of targeting bacteria and selectively being activated at infection sites

The clinical utility of colistin, a last-resort antibiotic against multidrug-resistant Gram-negative pathogens, is severely constrained by dose-limiting nephrotoxicity (up to 60% incidence) and poor infection-site targeting. Existing prodrug approaches, such as colistin methanesulfonate, rely on slow, non-selective hydrolysis that reduces systemic toxicity but also diminishes antibacterial efficacy at the infection foci. Here we report a conjugate strategy that combines infection-activatable release with bacterial targeting. A series of colistin prodrugs were synthesized by attaching a reactive oxygen species (ROS)-responsive phenylboronic acid linker to all primary amines of colistin, followed by covalent conjugation to sugars via boronic acid–diol complexation. The lead candidate, lactosyl-functionalized colistin prodrug (LaP-Col), exhibited minimal toxicity toward normal tissues and actively targeted bacteria. LaP-Col displayed a maximum tolerated dose exceeding that of colistin by more than 20-fold and minimal nephrotoxicity. In a murine model of Pseudomonas aeruginosa pneumonia, intravenous LaP-Col accumulated in infected lungs, effectively killed bacteria, and significantly improved therapeutic efficacy and survival rates. This prodrug architecture offers a generalizable route to mitigate the inherent toxicity of potent antimicrobial peptides while enhancing site-specific targeting.